Morgan Stanley’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $334K | Sell |
197,511
-50,883
| -20% | -$90.4K | ﹤0.01% | 5667 |
|
|
2025
Q4 | $353K | Buy |
248,394
+18,037
| +8% | +$26.3K | ﹤0.01% | 5691 |
|
|
2025
Q3 | $378K | Buy |
230,357
+18,342
| +9% | +$20.4K | ﹤0.01% | 5625 |
|
|
2025
Q2 | $155K | Buy |
212,015
+9,067
| +4% | +$7.83K | ﹤0.01% | 5953 |
|
|
2025
Q1 | $164K | Sell |
202,948
-1,908,354
| -90% | -$2.2M | ﹤0.01% | 5819 |
|
|
2024
Q4 | $2.91M | Buy |
2,111,302
+1,284,325
| +155% | +$1.44M | ﹤0.01% | 4427 |
|
|
2024
Q3 | $860K | Sell |
826,977
-729,873
| -47% | -$1M | ﹤0.01% | 5128 |
|
|
2024
Q2 | $2.69M | Sell |
1,556,850
-1,107,319
| -42% | -$2.23M | ﹤0.01% | 4358 |
|
|
2024
Q1 | $6.37M | Sell |
2,664,169
-1,475,537
| -36% | -$3.63M | ﹤0.01% | 3719 |
|
|
2023
Q4 | $13.8M | Buy |
4,139,706
+897,479
| +28% | +$2.4M | ﹤0.01% | 3660 |
|
|
2023
Q3 | $12.1M | Buy |
3,242,227
+227,107
| +8% | +$1.05M | ﹤0.01% | 2942 |
|
|
2023
Q2 | $12.9M | Buy |
3,015,120
+2,505,776
| +492% | +$14.8M | ﹤0.01% | 2923 |
|
|
2023
Q1 | $3.48M | Sell |
509,344
-204,647
| -29% | -$1.59M | ﹤0.01% | 4077 |
|
|
2022
Q4 | $5.65M | Buy |
713,991
+12,963
| +2% | +$99.7K | ﹤0.01% | 3644 |
|
|
2022
Q3 | $6.74M | Sell |
701,028
-112,108
| -14% | -$1.13M | ﹤0.01% | 3392 |
|
|
2022
Q2 | $5.89M | Buy |
813,136
+227,083
| +39% | +$1.97M | ﹤0.01% | 3609 |
|
|
2022
Q1 | $7.57M | Buy |
586,053
+182,755
| +45% | +$2.32M | ﹤0.01% | 3235 |
|
|
2021
Q4 | $6.44M | Sell |
403,298
-27,466
| -6% | -$480K | ﹤0.01% | 3453 |
|
|
2021
Q3 | $6.92M | Sell |
430,764
-194,036
| -31% | -$2.84M | ﹤0.01% | 3336 |
|
|
2021
Q2 | $8.64M | Sell |
624,800
-61,851
| -9% | -$876K | ﹤0.01% | 3153 |
|
|
2021
Q1 | $10M | Buy |
686,651
+110,457
| +19% | +$1.88M | ﹤0.01% | 2647 |
|
|
2020
Q4 | $10M | Buy |
576,194
+327,780
| +132% | +$5.84M | ﹤0.01% | 2506 |
|
|
2020
Q3 | $4.56M | Buy |
248,414
+20,801
| +9% | +$387K | ﹤0.01% | 2801 |
|
|
2020
Q2 | $4.07M | Buy |
227,613
+201,577
| +774% | +$3.41M | ﹤0.01% | 2881 |
|
|
2020
Q1 | $422K | Sell |
26,036
-222,861
| -90% | -$4.12M | ﹤0.01% | 4473 |
|
|
2019
Q4 | $4.48M | Buy |
248,897
+115,535
| +87% | +$2.13M | ﹤0.01% | 3311 |
|
|
2019
Q3 | $2.7M | Buy |
133,362
+75,475
| +130% | +$1.51M | ﹤0.01% | 3519 |
|
|
2019
Q2 | $1.28M | Buy |
57,887
+16,038
| +38% | +$279K | ﹤0.01% | 4089 |
|
|
2019
Q1 | $570K | Sell |
41,849
-41,329
| -50% | -$551K | ﹤0.01% | 4474 |
|
|
2018
Q4 | $753K | Sell |
83,178
-17,939
| -18% | -$208K | ﹤0.01% | 4498 |
|
|
2018
Q3 | $1.67M | Sell |
101,117
-193,326
| -66% | -$3.43M | ﹤0.01% | 4153 |
|
|
2018
Q2 | $4.12M | Buy |
294,443
+99,324
| +51% | +$1.42M | ﹤0.01% | 3370 |
|
|
2018
Q1 | $2.16M | Buy |
195,119
+110,239
| +130% | +$1.21M | ﹤0.01% | 3941 |
|
|
2017
Q4 | $747K | Buy |
84,880
+28,279
| +50% | +$303K | ﹤0.01% | 4745 |
|
|
2017
Q3 | $756K | Sell |
56,601
-4,268
| -7% | -$56.5K | ﹤0.01% | 4612 |
|
|
2017
Q2 | $874K | Buy |
60,869
+1,026
| +2% | +$19.7K | ﹤0.01% | 4471 |
|
|
2017
Q1 | $1.26M | Sell |
59,843
-86,306
| -59% | -$2.12M | ﹤0.01% | 4197 |
|
|
2016
Q4 | $4.11M | Buy |
146,149
+89,276
| +157% | +$2.5M | ﹤0.01% | 3202 |
|
|
2016
Q3 | $1.52M | Buy |
56,873
+54,941
| +2,844% | +$1.5M | ﹤0.01% | 3726 |
|
|
2016
Q2 | $33K | Sell |
1,932
-33,365
| -95% | -$626K | ﹤0.01% | 5674 |
|
|
2016
Q1 | $750K | Buy |
35,297
+31,690
| +879% | +$519K | ﹤0.01% | 4172 |
|
|
2015
Q4 | $83K | Sell |
3,607
-11,880
| -77% | -$306K | ﹤0.01% | 5503 |
|
|
2015
Q3 | $310K | Buy |
15,487
+5,952
| +62% | +$181K | ﹤0.01% | 4869 |
|
|
2015
Q2 | $276K | Buy |
9,535
+8,568
| +886% | +$217K | ﹤0.01% | 5088 |
|
|
2015
Q1 | $30K | Sell |
967
-57,806
| -98% | -$1.49M | ﹤0.01% | 5953 |
|
|
2014
Q4 | $959K | Buy |
+58,773
| New | +$829K | ﹤0.01% | 4183 |
|
Other funds holding CHRS
VCM
SB
KKRC
CM
CWG